Erlotinib in African Americans With Advanced Non–Small Cell Lung Cancer: A Prospective Randomized Study With Genetic and Pharmacokinetic Analyses
Author(s) -
M. A. Phelps,
Thomas E. Stinchcombe,
J. S. Blachly,
W. Zhao,
L. J. Schaaf,
S. L. Starrett,
L. Wei,
M. Poi,
D. Wang,
A. Papp,
J. Aimiuwu,
You-Han Gao,
J. Li,
G. A. Otterson,
W. J. Hicks,
Mark A. Socinski,
Miguel A. VillalonaCalero
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/05ak-3t14
Subject(s) - erlotinib , lung cancer , pharmacokinetics , medicine , oncology , randomized controlled trial , prospective cohort study , cancer , pharmacology , epidermal growth factor receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom